Menu
Recruiting NCT05785182

OCT in Open Fracture and Infected Fracture

— Observational Trauma Injury Trauma Open Fracture Fracture Infection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Open Fracture, Infected Fracture.
Who it may be relevant to
Registry conditions: Trauma Injury, Trauma, Open Fracture, Fracture Infection. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Optical Coherence Tomography Imaging to Visualize Bacteria or Biofilm on Hardware, Bone and Soft Tissue in Open Fracture and Infected Fracture

Overview

This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.

Interventions

  • Procedure Open Fracture
    Patients 18 years of age or older with open fracture. Provision of informed consent.
  • Procedure Infected Fracture
    Patients 18 years of age or older with infected fracture. Provision of informed consent.

Primary outcome measures

  • Feasibility and acceptability of OCT imaging [Time frame: 36 months]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • Open fracture
  • Fracture Related Infection

Exclusion criteria

  • Metatarsal fractures

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Dartmouth-Hitchcock Medical Center — Lebanon

Identifiers

NCT: NCT05785182 · STUDY02001786

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗